R A Koup

Identification of a human recent thymic emigrant phenotype.

R. Koup, L. Picker, D. Douek, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV‐1 human monoclonal antibody VRC01 in healthy adults

J. Mascola, R. Koup, R. Bailer, 2015, Clinical and experimental immunology.

Decay Kinetics of Human Immunodeficiency Virus-Specific CD8+ T Cells in Peripheral Blood after Initiation of Highly Active Antiretroviral Therapy

R. Koup, L. Picker, M. Betts, 2001, Journal of Virology.

Genotypic and phenotypic characterization of HIV-1 patients with primary infection.

D. Ho, Y. Cao, R. Koup, 1993, Science.

Effect of HIV on thymic function before and after antiretroviral therapy in children.

J L Sullivan, R. Koup, D. Douek, 2000, The Journal of infectious diseases.

Pharmacokinetics of nevirapine: initial single-rising-dose study in humans

J L Sullivan, R. Koup, C. Bova, 1993, Antimicrobial Agents and Chemotherapy.

Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques

A I Spira, D. Ho, Steven Wolinsky, 1996, The Journal of experimental medicine.

Development of the anti-gp120 antibody response during seroconversion to human immunodeficiency virus type 1

J. Moore, D. Ho, Y. Cao, 1994, Journal of virology.

Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by the dipyridodiazepinone BI-RG-587.

J L Sullivan, R. Koup, K. Grozinger, 1991, The Journal of infectious diseases.